Status:
COMPLETED
Optimizing Kidney Transplant Informed Consent
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
University of Alabama at Birmingham
Conditions:
End-stage Kidney Disease
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
The objective of this study is to evaluate kidney transplant candidates' comprehension about increased risk donor kidneys necessary for informed consent. We have developed a web-based tool that educat...
Detailed Description
The shortage of kidneys for kidney transplantation results in almost 10,000 deaths per year in the United States. One strategy to increase the number of available kidneys is to offer kidney transplant...
Eligibility Criteria
Inclusion
- English-speaking
- 21 years or older
- Kidney Transplant candidates eligible: 1) completed the first phase of transplant evaluation education, and 2) wait-listed patients expected to receive a transplant within the next 6 months, returning for re-evaluation.
Exclusion
- No special classes of study participants, including fetuses, neonates, prisoners, institutionalized individuals, or other vulnerable populations will be included in the proposed study. Although pregnant women will be eligible for participation in the study, they are unlikely to be selected for kidney transplantation.
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2015
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT01859884
Start Date
October 1 2013
End Date
November 1 2015
Last Update
November 20 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Alabama at Birmingham
Birmingham, Alabama, United States, 35233
2
Northwestern Memorial Hospital
Chicago, Illinois, United States, 60611